Current data from population-based studies strongly suggest that inflammatory bowel disease is not a predisposing factor for the development of lymphoma. However, the authors stress that continued vigilance is recommended during therapy as the duration of follow-up is limited.

T.S. Dharmarajan

Doctors Hila and Castell write that with the wide use of empiric trials of GERD medical therapy, 24-hour esophageal pH monitoring has its main indication in assessing patients with poor response to GERD therapy and those in whom an anti-reflux surgical procedure is contemplated.

In his article, Dr. Chait states that even though tests for evaluation and treatment of GERD in the elderly are the same as those for the general population, a more aggressive approach is warranted because of a higher incidence of complications.

Khursheed N. Jeejeebhoy